Leporini C.; Piro R.; Ursini F.; Maida F.; Palleria C.; Arturi F.; Pavia M.; De Sarro G.; Russo E., Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013–2016) analysis, «EXPERT OPINION ON DRUG SAFETY», 2016, 15, pp. 17 - 34 [articolo]
Ursini F.; Grembiale R.D.; D'Antona L.; Gallo E.; D'Angelo S.; Citraro R.; Visca P.; Olivieri I.; De Sarro G.; Perrotti N.; Russo E., Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis, «JOURNAL OF INVESTIGATIVE DERMATOLOGY», 2016, 136, pp. 1892 - 1894 [articolo]
Ursini F.; Russo E.; D'Angelo S.; Arturi F.; Hribal M.L.; D'Antona L.; Bruno C.; Tripepi G.; Naty S.; De Sarro G.; Olivieri I.; Grembiale R.D., Prevalence of undiagnosed diabetes in rheumatoid arthritis: An OGTT study, «MEDICINE», 2016, 95, pp. 1 - 7 [articolo]
Ursini F.; D'Angelo S.; Padula A.; Gilio M.; Russo E.; Naty S.; De Sarro G.; Grembiale R.D.; Olivieri I., Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on “Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study” by Tseng et al., Joint Bone Spine 2016;83:307–13, «JOINT BONE SPINE», 2016, 83, pp. 611 - 612 [articolo]
Ursini, Francesco; Russo, Emilio; Leporini, Christian; Calabria, Marilena; Bruno, Caterina; Tripolino, Cesare; Naty, Saverio; Grembiale, Rosa Daniela, Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy, «CASE REPORTS IN RHEUMATOLOGY», 2015, 2015, pp. 1 - 3 [replica/breve intervento]
Ursini F.; Grembiale A.; Naty S.; Grembiale R.D., Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients, «CLINICAL RHEUMATOLOGY», 2014, 33, pp. 1759 - 1764 [articolo]
Patane M.; Ciriaco M.; Chimirri S.; Ursini F.; Naty S.; Grembiale R.D.; Gallelli L.; De Sarro G.; Russo E., Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis, «ADVANCES IN PHARMACOLOGICAL SCIENCES», 2013, 2013, Article number: 313858, pp. 1 - 8 [articolo]
Ursini F.; Mauro D.; Naty S.; Gagliardi D.; Grembiale R.D., Improvement in insulin resistance after short-term treatment with abatacept: Case report and short review, «CLINICAL RHEUMATOLOGY», 2012, 31, pp. 1401 - 1402 [articolo]
Ursini F.; Naty S.; Grembiale R.D., Fibromyalgia and obesity: The hidden link, «RHEUMATOLOGY INTERNATIONAL», 2011, 31, pp. 1403 - 1408 [articolo]
Ursini F.; Pipicelli G.; Grembiale R.D., Efficacy and safety of duloxetine in fibromyalgia, «LA CLINICA TERAPEUTICA», 2010, 161, pp. 391 - 395 [articolo]
Ursini F.; Naty S.; Grembiale R.D., Infliximab and insulin resistance, «AUTOIMMUNITY REVIEWS», 2010, 9, pp. 536 - 539 [articolo]
Ursini F.; Naty S.; Mazzei V.; Spagnolo F.; Grembiale R.D., Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab, «INTERNATIONAL IMMUNOPHARMACOLOGY», 2010, 10, pp. 827 - 828 [articolo]
Ursini F.; Succurro E.; Grembiale A.; Rudi S.; Grembiale R.D.; Arturi F., Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab, «INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY», 2010, 23, pp. 961 - 963 [articolo]
Ursini F.; Succurro E.; Grembiale A.; Gagliardi D.A.P.; Arturi F., The HPA Axis in the pathogenesis of Chronic Fatigue Syndrome, «LA CLINICA TERAPEUTICA», 2010, 161, pp. 461 - 464 [articolo]
Lakshmikanth T.; Burke S.; Ali T.H.; Kimpfler S.; Ursini F.; Ruggeri L.; Capanni M.; Umansky V.; Paschen A.; Sucker A.; Pende D.; Groh V.; Biassoni R.; Hoglund P.; Kato M.; Shibuya K.; Schadendorf D.; Anichini A.; Ferrone S.; Velardi A.; Karre K.; Shibuya A.; Carbone E.; Colucci F., NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo, «THE JOURNAL OF CLINICAL INVESTIGATION», 2009, 119, pp. 1251 - 1263 [articolo]
